Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer

…, M Hebbar, L Hornez, A Harduin-Lepers, JP Peyrat… - Cancer research, 1998 - AACR
Increased sialylation, especially involving the Sialyl-Lewis a and Sialyl-Lewis X determinants,
has been reported in breast cancer. A multiplex reverse transcription-PCR method was …

Mutations at BRCA1: The Medullary Breast Carcinoma Revisited

…, D Stoppa-Lyonnet, BB Paillerets, JP Peyrat… - Cancer research, 1998 - AACR
BRCA1-associated breast cancers (BRCA1-BCs) frequently harbor a high histoprognostic
grade, p53 alterations, and estrogen receptor negativity. Although these parameters predict a …

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

…, CGJF Sweep, K Ulm, JP Peyrat… - Journal of the …, 2002 - academic.oup.com
Background: Urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) play
essential roles in tumor invasion and metastasis. High levels of both uPA and PAI-1 are …

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

…, N Boutry-Kryza, C Lasset, H Sobol, JP Peyrat… - Jama, 2015 - jamanetwork.com
Importance Limited information about the relationship between specific mutations
inBRCA1orBRCA2(BRCA1/2) and cancer risk exists. Objective To identify mutation-specific cancer …

[HTML][HTML] Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways

…, V Nurcombe, X Le Bourhis, B Boilly, JP Peyrat… - Journal of Biological …, 2001 - ASBMB
We show here that the neurotrophin nerve growth factor (NGF), which has been shown to
be a mitogen for breast cancer cells, also stimulates cell survival through a distinct signaling …

BRCA1 Wild-Type Allele Modifies Risk of Ovarian Cancer in Carriers of BRCA1 Germ-Line Mutations

…, A Chompret, YJ Bignon, JP Peyrat… - … Biomarkers & Prevention, 2003 - AACR
Strong inter- and intrafamilial variation of penetrance of breast and ovarian cancer is
observed in BRCA1 mutation carriers. The wild-type copy of the BRCA1 gene is a plausible …

Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase …

…, F Révillion, M Hebbar, L Hornez, JP Peyrat - Clinical cancer …, 2000 - AACR
We measured the expression of the type I growth factor receptor gene family [epidermal
growth factor receptor (EGFR), c-erbB-2, c-erbB-3 and c-erbB-4] in a series of 365 unselected …

Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells

…, H Louis, B Boilly, V Nurcombe, F Révillion, JP Peyrat… - Cancer research, 2001 - AACR
The class of molecular chaperones known as 14-3-3 is involved in the control of cellular
growth by virtue of its apparent regulation of various signaling pathways, including the Raf/…

Epstein-Barr virus (EBV) genome and expression in breast cancer tissue: effect of EBV infection of breast cancer cells on resistance to paclitaxel (Taxol)

…, N Bride, N Boualaga, T Bauchet, JP Peyrat… - Journal of …, 2006 - Am Soc Microbiol
The Epstein-Barr virus (EBV) has been detected in subsets of breast cancers. In order to
elaborate on these observations, we quantified by real-time PCR (Q-PCR) the EBV genome in …

Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis

M Hebbar, JP Peyrat, L Hornez… - … : Official Journal of …, 2000 - Wiley Online Library
Objective Endostatin is an angiogenesis inhibitor derived from type XVIII collagen. The aim
of this study was to determine the concentrations of circulating endostatin in patients with …